Exploring Nanocarriers in Breast Cancer Management - Softcover

Softcover

ISBN 10: 0443438269 ISBN 13: 9780443438264

Verlag: Academic Press, 2026

Inhaltsangabe

Exploring Nanocarriers in Breast Cancer Management comprehensively delves into the realm of nanocarrier systems, which have shown immense potential in the management of breast cancer. The scope of this book encompasses a thorough exploration of various nanocarrier systems, including, amongst others, liposomes, niosomes, and microneedles. It highlights recent advancements in these systems and their promising results in breast cancer treatment. Additionally, the book addresses the crucial aspects of toxicity and regulatory considerations associated with nanocarriers. It aims to provide a foundational understanding of nanocarriers, their unique features, and their significant role in breast cancer management.

As breast cancer remains one of the most prevalent forms of cancer today, with no definitive cure currently available, this book is an essential resource for researchers, healthcare professionals, and anyone interested in cutting-edge developments in breast cancer treatment.

Über diesen Titel

Über die Autorinnen und Autoren

Dr. Amarjitsing Rajput is currently working as an Assistant Professor in the Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth, Deemed to be University, Pune, Maharashtra, India. He received his Ph. D. from Department of Pharmaceutics Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat in 2021. He completed his M. Pharmacy in Pharmaceutics from North Maharashtra University, Jalgaon, Maharashtra. During his doctoral research, he worked on nanostructured lipid carriers and liposomes to manage Alzheimer’s disease. He continued his Postdoctoral Research at the Department of Biosciences and Bioengineering (BSBE), Indian Institute of Technology Bombay (IITB), Mumbai, India. His area of research includes nanocarriers, microneedle technology, brain targeting, and transdermal drug delivery to manage skin diseases. To his credit, he has more than 35 publications in numerous National and International journals of repute and 15 book chapters. Moreover, he reviews many esteemed international journals,

Dr Mandlik holds the following degrees: M. Pharm, Ph.D (Pharmacology). Dr Mandlik has been a researcher and lecturer for over 10 years. Dr Mandlik’s research interests include: hepatoprotection; inflammation and immunity; gene transactivation and transrepression; anti-diabetic studies; and toxicity studies

Mr. Praveen Subbappa is a seasoned pharmaceutical executive with over 25 years of experience in the industry. Currently, he serves as the Associate Vice President of Alliance Management at Azurity Pharmaceuticals in the USA. Praveen holds a postgraduate degree in Pharmaceutics from the Government College of Pharmacy, Bengaluru. Throughout his distinguished career, Praveen has held pivotal roles in renowned pharmaceutical companies such as Dr. Reddy’s Laboratories Inc, Slayback Pharma LLC, and Bharat Serums & Vaccines, where he has led critical functions such as Research & Development, Technology Transfer, and Regulatory Affairs

Dr. Sudarshan Singh is presently working as a Frontier Proactive Researcher at Chiang Mai University, Thailand. He has authored several technical books and book chapters, and more than two hundred research and review papers in reputable peer-reviewed journals. He has five registered patents to his credit. He serves as a reviewer for numerous international journals. He has eleven years of teaching experience in undergraduate and postgraduate pharmacy courses, with more than six years of postdoctoral research experience. He has mentored numerous undergraduate and postgraduate students in their project work. Moreover, during his postdoctoral research at Prince of Songkhla University, Walailak University, and Chiang Mai University, Thailand, he co-supervised doctoral students and received the Top Researcher Award for the year 2020–2021. He is a life member of professional bodies such as the Society of Pharmacovigilance India and a registered pharmacist with the State Pharmacy Council of Chhattisgarh, India.

Von der hinteren Coverseite

Exploring Nanocarriers in Breast Cancer Management is a comprehensive book that delves into the realm of nanocarrier systems, which have shown immense potential in the management of breast cancer. Breast cancer remains one of the most prevalent forms of cancer today, with no definitive cure currently available. This underscores the critical need for innovative drug delivery systems that offer greater target specificity and reduced side effects. The scope of this book encompasses a thorough exploration of various nanocarrier systems, including amongst others liposomes, niosomes,s, and microneedles. It highlights the recent advancements in these systems and their promising results in breast cancer treatment.

Additionally, the book addresses the crucial aspects of toxicity and regulatory considerations associated with nanocarriers. This book aims to provide a foundational understanding of nanocarriers, their unique features, and their significant role in breast cancer management. It is an essential resource for researchers, healthcare professionals, and anyone interested in the cutting-edge developments in breast cancer treatment.

Details zur Ausgabe

• Verlag: Academic Press
• Erscheinungsdatum: 2026
• Sprache: Englisch
• ISBN 10: 0443438269
• ISBN 13: 9780443438264
• Einband: Taschenbuch
• Anzahl der Seiten: 328
• Herausgeber: Rajput PhD. Amarjitsing, Mandlik Satish, Subbappa PhD. Praveen, Singh PhD. Sudarshan
• Kontakt zum Hersteller: Academic Press; https://shop.elsevier.com/; ; 230 PARK AVENUE, SUITE 800; NY; NY; 10169; USA
• Verantwortliche Person: eVatmaster Consulting GmbH; 497000000000; contact@evatmaster.com; ; Bettinastr. 30,60325; Frankfurt am Main; 60325; Deutschland